EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Gonadal function and pathology in 17beta-HSD 3 and 5alpha-reductase deficiency

Lidewij S Boogers iD, Hennie T Brüggenwirth, Katja P Wolffenbuttel, Remko Hersmus, Jillian Bryce, S Faisal Ahmed, Angela K Lucas-Herald iD, Federico Baronio, Martine Cools, Mona Ellaithi, Evgenia Globa, Tülay Güran iD und 10 weitere

European Journal of Endocrinology · 2025

DOI: 10.1093/ejendo/lvae154 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Endocrinology, 2025. Verfasst von Lidewij S Boogers und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Endocrinology, Erasmus University Medical Centre, 3015 GD Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: 17-Hydroxysteroid Dehydrogenases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: I-DSD Registry project, Neurocrine Biosciences, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

17β-Hydroxysteroid dehydrogenase 3 deficiency (17β-HSDD) and 5α-reductase type 2 deficiency (5α-RD) are rare 46,XY differences of sex development (DSD). This study aims to enlarge the limited knowledge on long-term gonadal function and gonadal pathology in these conditions.

Design

Retrospective multicentre cohort study.

Methods

Data on phenotype, laboratory results, and hormone treatment were collected from patients aged ≥16 years at time of data collection with genetically confirmed 17β-HSDD and 5α-RD from 10 centres via the I-DSD Registry. If gonadectomy or gonadal biopsy had been performed, pathology reports and/or gonadal tissue or images were collected.

Results

All 16 patients with 17β-HSDD were raised female; 1 (6%) changed to male gender at age 14. Three females were treated with gonadotrophin-releasing hormone agonists (GnRHa) to prevent virilisation. Thirteen underwent gonadectomy at median age 8 (range 0-17). None had germ cell (pre)malignancies. Of 14 patients with 5α-RD, 10 (71%) were raised female. Five changed gender at age 7-23, of whom 4 to male gender. One was treated with GnRHa. Six underwent gonadectomy at median age 10 (range 0-31). None had germ cell (pre)malignancies. With gonads in situ, puberty spontaneously progressed. Three were treated with dihydrotestosterone.

Conclusions

A significant percentage of individuals with 17β-HSDD and 5α-RD changed gender, and some were treated with GnRHa to prevent virilisation before making a definitive decision about gonadectomy. When left in situ, spontaneous puberty occurs and germ cell (pre)malignancies seem uncommon at least until early adulthood. Together, these data support delaying a decision about gonadectomy until late adolescence in these conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

17-Hydroxysteroid DehydrogenasesHumansFemaleMaleAdolescentRetrospective StudiesAdultChildYoung AdultDisorder of Sex Development, 46,XY3-Oxo-5-alpha-Steroid 4-DehydrogenaseGonadsCohort Studies

Stichwörter der Autor:innen

17beta-HSD deficiency5alpha-reductase deficiencydisorder of sex developmentgerm cell cancerhypogonadismpubertytestis

Substanzen

17-Hydroxysteroid Dehydrogenases3-Oxo-5-alpha-Steroid 4-Dehydrogenase17beta-hydroxysteroid dehydrogenase type 3

Autor:innen und Institutionen

  • Department of Paediatric Endocrinology, Erasmus University Medical Centre, 3015 GD Rotterdam, The Netherlands.
  • Department of Paediatric Endocrinology, Amsterdam UMC location Vrije Universiteit Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Department of Clinical Genetics, Erasmus University Medical Centre, 3015 CN Rotterdam, The Netherlands.
  • Center of Expertise for DSD, Erasmus University Medical Centre, 3015 GD Rotterdam, The Netherlands.
  • Department of Urology and Paediatric Urology, Erasmus University Medical Centre, 3015 CN Rotterdam, The Netherlands.
  • Department of Pathology, Erasmus University Medical Centre, 3015 CN Rotterdam, The Netherlands.

ORCID-Profile: Lidewij S Boogers, Angela K Lucas-Herald, Tülay Güran, Olaf Hiort, Paul-Martin Holterhus, Buşra G Tosun

Förderung

  • I-DSD Registry project
  • Neurocrine Biosciences
  • Medical Research Council
  • Seventh European Union Framework Program
  • European Society for Paediatric Endocrinology

Zitieren

APA

Boogers, L. S., Brüggenwirth, H. T., Wolffenbuttel, K. P., Hersmus, R., Bryce, J., Ahmed, S. F., Lucas-Herald, A. K., Baronio, F., Cools, M., Ellaithi, M., Globa, E., Güran, T., Hiort, O., Holterhus, P. M., McElreavey, K., Niedziela, M., Stancampiano, M. R., Tosun, B. G., van Bever, Y., …, & Hannema, S. E. (2025). Gonadal function and pathology in 17beta-HSD 3 and 5alpha-reductase deficiency. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae154

Vancouver

Boogers LS, Brüggenwirth HT, Wolffenbuttel KP, Hersmus R, Bryce J, Ahmed SF, et al. Gonadal function and pathology in 17beta-HSD 3 and 5alpha-reductase deficiency. European Journal of Endocrinology. 2025. doi:10.1093/ejendo/lvae154

BibTeX
@article{Boogers2025,
  author = {Boogers, Lidewij S and Brüggenwirth, Hennie T and Wolffenbuttel, Katja P and Hersmus, Remko and Bryce, Jillian and Ahmed, S Faisal and Lucas-Herald, Angela K and Baronio, Federico and Cools, Martine and Ellaithi, Mona and Globa, Evgenia and Güran, Tülay and Hiort, Olaf and Holterhus, Paul-Martin and McElreavey, Kenneth and Niedziela, Marek and Stancampiano, Marianna Rita and Tosun, Buşra G and van Bever, Yolande and Oosterhuis, J Wolter and Looijenga, Leendert H J and Hannema, Sabine E},
  title = {Gonadal function and pathology in 17beta-HSD 3 and 5alpha-reductase deficiency},
  journal = {European Journal of Endocrinology},
  year = {2025},
  doi = {10.1093/ejendo/lvae154}
}
Kostenlos starten →